MedTrace Logo

SZMN Blocks for Pain Control in Pediatric Patients Undergoing T&A

NCT04797559 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-08-14

No results posted yet for this study

Summary

The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures, however, have not been studied for patients undergoing tonsillectomy and adenoidectomy (T\&A) procedures. The goals of this study are to determine if SZMN block can be utilized for pain control and decrease morbidity in pediatric patients undergoing T\&A.

Conditions

  • Postoperative Pain
  • Opioid Use

Interventions

PROCEDURE

SZMN Block

Suprazygomatic Maxillary Nerve (SZMN) Blocks bilaterally near the temples of the patient

Sponsors & Collaborators

Principal Investigators

  • Ban C Tsui, MD · Professor

  • Carole Lin, MD · Pediatric Anesthesiologist

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-29
Primary Completion
2023-04-19
Completion
2023-04-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04797559 on ClinicalTrials.gov